Australian Prescriber: Two viewpoints on deferring PBAC recommendations

Earlier in 2011 the government deferred the listing of seven medicines and one vaccine on the Pharmaceutical Benefits Scheme (PBS). Two opinion pieces examining this issue are now available on the website of Australian Prescriber.

The articles — Deferring PBAC decisions: industry view by Brendan Shaw, Chief Executive, Medicines  Australia and Deferring PBAC decisions: rationing as a reality by Rob Moulds, Medical adviser, Therapeutic Guidelines Ltd — provide two differing views about the decision by government to defer the listing of these medicines.

Both articles are available online under ‘Latest News’ at australianprescriber.com.

ENDS

Independent, evidence-based and not-for-profit, NPS enables better decisions about medicines and medical tests.We are funded by the Australian Government Department of Health and Ageing.

Australian Prescriber is an independent peer-reviewed journal providing critical commentary on therapeutic topics for health professionals, particularly doctors in general practice. It is published by NPS, an independent, not-for-profit organisation for quality use of medicines funded by the Australian Government Department of Health and Ageing. Australian Prescriber is published every two months, in hard copy that is distributed to health professionals free of charge, and online in full text at www.australianprescriber.com